Japan drug maker Novartis, in trouble again!

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

Singapore: In an internal probing by the Novartis Pharma, it was revealed that its employees in Japan had failed to report about 10,000 cases of serious side effects caused by its drugs for...Read more

Spectrometry leader BiologicsFocus starts biologics initiative

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 Sep, 2012

Singapore: AB SCIEX, a global leader in life science analytical technologies, announced a global initiative focused on biologics. This new initiative is in response to the fundamental shif...Read more

Eisai subsidiary opens antibody facility in the US

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Aug, 2012

Singapore: Eisai's US subsidiary Morphotek has opened a new pilot manufacturing plant in Exton, Pennsylvania, for the production of antibodies to support its early-stage clinical trials. Th...Read more

Riken launches joint research centers in India

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2013

Singapore: Japan's largest research organization, Riken has launched two virtual Joint Research Centers with India's premier institution the National Center for Biological Sciences (NCBS), ...Read more

Mistubishi to elevate particle therapy portfolio

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2014

Singapore: Japanese firm, Mitsubishi Electric Corporation, is gearing up to solidify its presence in the bioscience sector. The company has expanded its particle therapy business in Japan a...Read more

Daiichi Sankyo kids tumor drug gets Japanese nod

Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

Singapore: Daiichi Sankyo received approval for a supplemental new drug application (sNDA) for an additional indication for Topotecin intravenous drip infusion 40 mg and 100 mg (irinotecan ...Read more

Daiichi, Ranbaxy integrate Thailand business

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jan, 2013

Singapore: Daiichi Sankyo and Ranbaxy Laboratories will integrate their business operations in Thailand, in order to leverage and maximize the synergies of the Hybrid Business Model. Accor...Read more

Takeda to acquire LigoCyte Pharmaceuticals

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Oct, 2012

Singapore: The wholly owned subsidiary of Japan-based Takeda Pharmaceutical, Takeda America Holdings, has entered into a definitive agreement with LigoCyte Pharmaceuticals to acquire LigoCy...Read more

Astellas, UCB launch Cimzia in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 11 Mar, 2013

Singapore: Astellas Pharma and UCB Japan have launched Cimzia (certolizumab pegol) in Japan for adult patients with rheumatoid arthritis (RA) who have had an inadequate response to conventi...Read more

BabyLance safety heelstick receives EU patent

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Aug, 2013

Singapore: US-based MediPurpose, a master distributor and manufacturer of medical products, has announced an addition to its expanding portfolio of lancet patents. The medical product comp...Read more

Museum gets $250,000 from Takeda to train teachers

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2012

Singapore: Takeda announced that it will donate $250,000 to Chicago's Museum of Science and Industry mainly to support science teacher education programs offered through the Museum's Cente...Read more

Eisai, Biogen boost manufacturing in US

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2012

Singapore: Eisai's US subsidiary entered into a strategic manufacturing alliance with Biogen Idec to bolster the manufacturing capabilities of both companies through the joint utilization ...Read more

KHK advances DsiRNA cancer target, pays $5 mn

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jan, 2013

Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology therapeutics, announced that Kyowa Hakko Kirin (KHK) has elected to advanc...Read more

BMS seeks Hep C therapy approval in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

Singapore: Bristol-Myers Squibb has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Devices Agency seeking the world's first interferon-free and ribavirin-free ...Read more

Daiichi US appoints Glenn Gormley as chairman

Japan |  Influencers | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2013

Singapore: Daiichi Sankyo has appointed Dr Glenn Gormley, as president and chairman of Daiichi Sankyo, US. Dr Gormley will also continue in his existing roles as president, Daiichi Sankyo ...Read more

Catalent, UMN collaborate for biosimilars

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 Dec, 2012

Singapore: Catalent Pharma Solutions and UMN Pharma announced the signing of an agreement to provide UMN Pharma a broad range of biosimilar cell lines using Catalent's proprietary GPEx te...Read more

Daiichi Sankyo generics' unit to launch 5 drugs

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2012

Singapore: Daiichi Sankyo's pharmaceuticals subsidiary, Daiichi Sankyo Espha is all set to launch five generic products Quetiapine tablets 25 mg DSEP, Quetiapine tablets 100 mg DSEP and Que...Read more

Medtronic to help rebuild hospital in Japan

Japan |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

Singapore: Medtronic Foundation will partner with Project HOPE to rebuild the Yamada General Hospital in Japan's northern coastal town of Yamada. The hospital was destroyed in the earthquak...Read more